Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

NOI - PCA-NHLBI-07088

Active
75N98026Q00630Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, is issuing a non-competitive combined synopsis/solicitation under solicitation number 75N98026Q00630 to procure two complete CD Leycom INCA Pressure-Volume Loop Systems along with associated accessories, disposable catheters, and platinum-level training and support. This procurement supports clinical studies conducted by the National Heart, Lung, and Blood Institute’s Laboratory of Cardiovascular Intervention under an Investigational Device Exemption. The purchase will be awarded as a firm-fixed-price order to CD Leycom BV, the sole worldwide manufacturer of this invasive conductance-catheter-based system, which holds FDA 510(k) market clearance for clinical use in human patients. Due to the unique capabilities of CD Leycom’s system and its regulatory approval status, no other vendor can provide an equivalent product, justifying the non-competitive acquisition approach. This acquisition is conducted under FAR Part 12.603 for streamlined solicitation of commercial products and services and falls below the simplified acquisition threshold. It is issued as a Notice of Intent without plans for full and open competition, referencing authorities including FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901. The applicable NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees; however, this requirement is not set aside for small businesses. The solicitation incorporates provisions effective as of March 13, 2026, per the latest Federal Acquisition Circular. The response deadline is set for June 23, 2026, with point of contact information provided for coordination.

General Info

NIH procures two CD Leycom INCA Pressure-Volume Loop Systems non-competitively for clinical studies.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(1)

RFQ 75N98026Q00630 for CD Leycom INCA PV Loop Systems

PDFrfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseCombined Synopsis
Posted

Combined Synopsis

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00630. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a purchase order without providing for full and open competition (brand-name).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to CD Leycom BV, Asveldweg 2, 7556 BP Hengelo, The Netherlands (U.S. point of contact: Patrick Sullivan, +1 (817) 879-9670; SAM.gov UEI: JLLJMU81NKV4), for two (2) complete CD Leycom INCA Pressure-Volume (PV) Loop Systems with associated accessories, disposable 7F PV loop catheters, and Platinum-level training and support, in support of the National Heart, Lung, and Blood Institute (NHLBI) Laboratory of Cardiovascular Intervention (LCI) SESAME clinical studies conducted under Investigational Device Exemption (IDE) G220158. CD Leycom BV is the sole commercial manufacturer worldwide of an invasive conductance-catheter-based pressure-volume loop recording system holding FDA 510(k) market clearance for use in human patients; no other vendor offers an equivalent system approved for clinical human use.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective March 13, 2026.
(iv) The associated NAICS code is 334516 ¿ Analytical Laboratory Instrument Manufacturing, and the small business size standard is 1,000 employees. This requirement is not set aside for small business.

Similar Contracts

NAICS: 334516
New
Federal
FY26 Lab Consolidation for Coagulation CPRR EffortThe contract solicits a comprehensive Cost Per Reportable Result (CPRR) agreement to supply and support coagulation analyzers for multiple Military Treatment Facilities (MTFs) under the Defense Health Agency HCD West. Spanning one base year with four option years, the contract encompasses all aspects necessary for effective coagulation testing, including the provision of coagulation analyzer equipment, reagents, consumables, controls, peripherals such as printers and uninterrupted power supplies, and all parts needed to ensure proper instrument operation. The CPRR price covers every element required to generate a single patient reportable result, including dilution, repeat and confirmatory testing, as well as quality control and calibration per Clinical Laboratory Standards Institute guidelines. The contractor is responsible for delivery, installation, removal, preventive maintenance, repairs, and ensuring continuous, uninterrupted analyzer operation even in cases of interface failures with laboratory information systems or electronic health records. In addition to equipment and consumables, the contract requires comprehensive training for government personnel, offering user-level and advanced super-user training sessions at both the installation sites and contractor facilities, with contractor-borne travel expenses for the latter. The analyzers must be new, FDA-approved, and capable of seamless bidirectional interfacing with existing Department of Defense electronic health records and laboratory management systems. The scope also includes managing hazardous waste generated during testing and accommodating varying workload volumes, surge capacity, and volume adjustments at different MTFs. Detailed site-specific data informs equipment deployment, covering delivery schedules, physical requirements, power needs, and anticipated test volumes for various coagulation assays such as Prothrombin Time and Activated Partial Thromboplastin Time. The contractor is tasked with providing ongoing operational and technical support, monthly reporting, and ensuring overall performance quality throughout the contract term.
Defense Health Agency Hcd West

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 334516
New
Federal
Protective Clothing Blood Penetration Resistance TesterThe U.S. Food and Drug Administration’s Center for Devices and Radiological Health is conducting a market research effort to identify small businesses capable of supplying a Protective Clothing Blood Penetration Resistance Tester. This device is intended to automate and improve the testing of level 4 medical gowns for viral penetration resistance, significantly reducing manual testing time while enhancing consistency and repeatability. The instrument must meet several technical specifications, including the ability to run four simultaneous tests, automatic timing functions, real-time pressure monitoring, and compliance with ASTM F1670 and ASTM F1671 standards. The system must be new, turn-key, and include all necessary hardware, software, manuals, installation, training, and qualification documentation. Interested firms, particularly small businesses under NAICS code 334516, are invited to submit capability statements by June 23, 2026. Responses should include detailed company information, past performance data, technical compliance evidence, warranty terms, and manufacturing origin to facilitate evaluation under Buy American requirements. The delivery location is the FDA’s Winchester Engineering and Analytical Center in Massachusetts, with delivery expected within 120 days of award. This announcement does not constitute a solicitation or binding contract but serves as an information-gathering step for potential future procurements.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 7 days
View Details